Delic Corp the leading psychedelic wellness platform today announced that its subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent, a global leader in life sciences, diagnostics, and applied chemical markets. Under the agreement, Agilent will refer its clients interested in cannabis and hemp analytics and new product development to DELIC Labs and in turn, DELIC Labs will recommend Agilent analytical equipment to its clients looking to purchase new systems. Both companies will participate in sales and marketing initiatives, referrals and instrument training. 

Co-Marketing Partnership to Expand Reach of Both Companies in the Cannabis and Analytics Space

“Partnering with Agilent, the dominant global analytics experts, is a powerful step for DELIC Labs and brings our cannabis and hemp experience to their broad range of clients, including large pharmaceutical companies,” said DELIC Labs founder and CEO Dr. Markus Roggen. “Our combined expertise will help solve many issues for those exploring the cannabis industry and developing new and unique products to serve an increasingly growing consumer and patient base.” 

“Agilent is well-regarded as the premier scientific destination for analytical science and we are honored to collaborate with them through our team at DELIC Labs,” said Matt Stang, Delic CEO and co-founder. “Delic is committed to bringing innovative natural wellness remedies to the general public and this partnership will open up enterprise opportunities for pioneering companies.” 

“We continually strive to meet the needs of our customers and there has been a significant interest in cannabis and hemp analytics as well as new product development,” said Greg Kozadjian, Emerging Markets, Business Development, Agilent Technologies. “Partnering with the team at DELIC Labs is a natural fit as they are at the forefront of legal cannabis analytics and research. We are excited to leverage their domain expertise.”